Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$75.36 - $112.51 $459,997 - $686,761
6,104 New
6,104 $488,000
Q3 2023

Nov 14, 2023

BUY
$97.55 - $135.91 $587,348 - $818,314
6,021 New
6,021 $607,000
Q4 2022

Feb 14, 2023

SELL
$72.84 - $94.04 $174,816 - $225,696
-2,400 Reduced 30.97%
5,349 $474,000
Q3 2022

Nov 14, 2022

BUY
$77.78 - $103.92 $602,717 - $805,276
7,749 New
7,749 $621,000
Q4 2020

Feb 12, 2021

SELL
$77.7 - $112.82 $418,492 - $607,648
-5,386 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$69.87 - $89.2 $244,265 - $311,843
-3,496 Reduced 39.36%
5,386 $424,000
Q2 2020

Aug 14, 2020

BUY
$50.31 - $81.76 $9,055 - $14,716
180 Added 2.07%
8,882 $639,000
Q1 2020

May 15, 2020

BUY
$39.81 - $112.01 $207,012 - $582,452
5,200 Added 148.49%
8,702 $498,000
Q4 2019

Feb 14, 2020

BUY
$93.31 - $116.55 $326,771 - $408,158
3,502 New
3,502 $392,000
Q4 2018

Feb 13, 2019

SELL
$57.41 - $79.06 $212,359 - $292,442
-3,699 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$73.09 - $81.64 $36,545 - $40,820
-500 Reduced 11.91%
3,699 $293,000
Q2 2018

Aug 14, 2018

BUY
$61.34 - $76.43 $257,566 - $320,929
4,199 New
4,199 $307,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.